HER2-targeted therapies in cancer: a systematic review

Abstract Abnormal alterations in human epidermal growth factor receptor 2 (HER2, neu, and erbB2) are associated with the development of many tumors. It is currently a crucial treatment for multiple cancers. Advanced in molecular biology and further exploration of the HER2-mediated pathway have promo...

Full description

Bibliographic Details
Main Authors: Kunrui Zhu, Xinyi Yang, Hebei Tai, Xiaorong Zhong, Ting Luo, Hong Zheng
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Biomarker Research
Subjects:
Online Access:https://doi.org/10.1186/s40364-024-00565-1